CGRP receptor antagonists
US10888561B2 · kind B2 · utility
1Cited by
28References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 2019 |
| Grant date | Jan 12, 2021 |
| Priority date | — |
| Expiry date | Apr 8, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosures herein relate to novel compounds of formula wherein R1, R2, R3 and R4 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.